Article
Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment.
Journal of translational medicine - 31 Oct 2017
Li Xiaoyan, Zhou Liang, Gu Lin, Gu Yurong, Chen Lubiao, Lian Yifan, Huang Yuehua
Abstract excerpt
BACKGROUND: There is limited information on innate immunity, especially natural killer (NK) cell function, in different chronic hepatitis B (CHB) stages. Therefore, we examined whether the clinical staging strategy accurately reflects veritable NK cell immunity. METHODS: A total of 237 eligible CHB patients and 22 healthy controls were enrolled in our study. Demographic and clinical data were collected, and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
